by Marcela Shine | Oct 6, 2017 | Companies that Care, Our Blog
Today was a busy day for The Tutu Project! We met with metastatic breast cancer patient advocacy leaders at AstraZeneca’s roundtable meeting to discuss the challenges the community faces and ways to collaboratively address patient needs. After the meeting, we joined... by The Tutu Team | Oct 11, 2016 | Uncategorized
Summary After its failed attempts for a merger with Allergan and AstraZeneca to bolster its drug portfolio, Pfizer has to heavily rely on its current blockbuster drugs. Pfizer’s blockbuster drugs face growth challenges such as losing patent protection,... by The Tutu Team | Oct 10, 2016 | Uncategorized
Lung cancer trial results showed a win for Merck and a loss for Bristol-Myers. (tycoon101 – Fotolia/stock.adobe.com) Bristol-Myers Squibb (BMY) stock crashed to a two-year low Monday after competitor Merck (MRK) unveiled Phase 3 results showing lung-cancer drug... 